Phase 3 Study to Treat Patients With Soft Tissue Sarcomas
Public ClinicalTrials.gov record NCT02049905. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Open-Label Phase 3 Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Investigator's Choice in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcomas Who Either Relapsed or Were Refractory to Prior Non-Adjuvant Chemotherapy
Study identification
- NCT ID
- NCT02049905
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- ImmunityBio, Inc.
- Industry
- Enrollment
- 433 participants
Conditions and interventions
Interventions
- Aldoxorubicin Drug
- Investigator's Choice Treatment (Darcabazine, Pazopanib, Gemcitabine + Docetaxel, Doxorubicin, Ifosfamide) Drug
Drug
Eligibility (public fields only)
- Age range
- 15 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2013
- Primary completion
- Apr 30, 2017
- Completion
- Apr 30, 2017
- Last update posted
- Jun 12, 2024
2014 – 2017
United States locations
- U.S. sites
- 36
- U.S. states
- 21
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35243 | — |
| Arizona Oncology Associates, PC | Phoenix | Arizona | 85016 | — |
| The University of Arizona | Tucson | Arizona | 85719 | — |
| City of Hope Medical Group | Duarte | California | 91010 | — |
| Samuel Oschin Cancer Center | Los Angeles | California | 90048 | — |
| UCLA Medical Center | Los Angeles | California | 90095 | — |
| Sarcoma Oncology Center | Santa Monica | California | 940403 | — |
| Stanford University Medical Center | Stanford | California | 94305 | — |
| U of CO Health Sciences Center | Aurora | Colorado | 80045 | — |
| Rocky Mountain Cancer Centers | Denver | Colorado | 80218 | — |
| Mayo Clinic | Jacksonville | Florida | 32224 | — |
| Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| Georgia Cancer Specialists | Atlanta | Georgia | 30341 | — |
| Northwestern Medical Faculty Foundation | Chicago | Illinois | 60611 | — |
| Edward Cancer Center | Naperville | Illinois | 60540 | — |
| Oncology Specialists, SC | Niles | Illinois | 60714 | — |
| Kansas City Cancer Center | Overland Park | Kansas | 66210 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02115 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Washington University | St Louis | Missouri | 63110 | — |
| Nebraska Methodist Hospital | Omaha | Nebraska | 68114 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| Levine Cancer Institute | Charlotte | North Carolina | 28204 | — |
| Wake Forest University Baptist Medical Center | Winston-Salem | North Carolina | 27157 | — |
| University Hospitals Case Medical Center | Cleveland | Ohio | 44106 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| The James Cancer Hospital and Solove Research Institute | Columbus | Ohio | 43202 | — |
| Center for Health and Healing | Portland | Oregon | 97239 | — |
| Jefferson Medical College | Philadelphia | Pennsylvania | 19107 | — |
| U of Pittsburgh Cancer Institute | Pittsburgh | Pennsylvania | 15232 | — |
| Vanderbilt University | Nashville | Tennessee | 37212 | — |
| Fletcher Allen Health Care | Burlington | Vermont | 05405 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02049905, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 12, 2024 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02049905 live on ClinicalTrials.gov.